Sanofi to offer insulin product for $35 to all Americans through GoodRx

Sanofi to offer insulin product for  to all Americans through GoodRx


Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019.

Alex Flynn | Bloomberg | Getty Images

Americans, regardless of their insurance status, can now access Sanofi‘s most widely prescribed insulin for $35 through the prescription drug savings company GoodRx, the companies announced Thursday. 

Patients with a valid prescription can specifically access a $35 coupon for Sanofi’s Lantus on GoodRx’s site and redeem it at more than 70,000 retail pharmacies across the U.S., including CVS, Walgreens and Walmart

The effort aims to make the $35 price point for Lantus more widely accessible to Americans, even after Sanofi – along with its rivals Eli Lilly and Novo Nordisk – announced sweeping insulin price cuts and out-of-pocket cost caps earlier this year.

Those three companies, which control over 90% of the global insulin market, moved to slash prices after years of political pressure and public outrage over the high costs of diabetes care in the U.S. Americans pay roughly eight times more for insulin than other developed countries, making diabetes the country’s most expensive chronic condition.

Sanofi said in March that it would lower list prices for Lantus and cap out-of-pocket costs for people with insurance at $35 a month. But the change won’t be effective until January. 

The French company also has an existing patient assistance program to cap insulin prices for uninsured diabetes patients at the same price. But some patients have struggled to access the $35 price point, even with that program in place. 

That’s due to low awareness among patients about copay cards and patient savings programs that can assist with out-of-pocket costs. Health experts and patient advocates have raised concerns that those programs, which manufacturers run, often require people to jump through hoops just to save money. 

Pharma companies spend more than $5 billion on marketing patient support programs every year, but only 3% of patients actually use them, according to a 2021 survey from Phreesia Life Sciences.

President Joe Biden’s Inflation Reduction Act also capped monthly insulin costs for Medicare beneficiaries at $35, but it did not provide protection to diabetes patients who have private insurance.

Roughly 37 million people in the U.S., or 11.3% of the country’s population, have diabetes, according to the Centers for Disease Control and Prevention. Approximately 8.4 million diabetes patients rely on insulin, the American Diabetes Association said.



Source

Supreme Court endorses Obamacare panel that requires free preventive care
Health

Supreme Court endorses Obamacare panel that requires free preventive care

Demonstrators in support of U.S. President Barack Obama’s health-care law, the Affordable Care Act (ACA), hold up ‘ACA is Here to Stay’ signs after the U.S. Supreme Court ruled 6-3 to save Obamacare tax subsidies outside the Supreme Court in Washington, D.C. June 25, 2015. Andrew Harrer | Bloomberg | Getty Images WASHINGTON — The […]

Read More
Supreme Court rules for South Carolina over bid to defund Planned Parenthood
Health

Supreme Court rules for South Carolina over bid to defund Planned Parenthood

Planned Parenthood signage is displayed outside of a health care clinic in Los Angeles, California on May 16, 2023.  Patrick T. Fallon | AFP | Getty Images WASHINGTON — The Supreme Court on Thursday ruled for South Carolina over its effort to defund Planned Parenthood, concluding that individual Medicaid patients cannot sue to enforce their […]

Read More
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Health

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Competition in […]

Read More